These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34330048)

  • 21. Increased volume of the amygdala and hippocampus in bipolar patients treated with lithium.
    Foland LC; Altshuler LL; Sugar CA; Lee AD; Leow AD; Townsend J; Narr KL; Asuncion DM; Toga AW; Thompson PM
    Neuroreport; 2008 Jan; 19(2):221-4. PubMed ID: 18185112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder.
    Bearden CE; Thompson PM; Dutton RA; Frey BN; Peluso MA; Nicoletti M; Dierschke N; Hayashi KM; Klunder AD; Glahn DC; Brambilla P; Sassi RB; Mallinger AG; Soares JC
    Neuropsychopharmacology; 2008 May; 33(6):1229-38. PubMed ID: 17687266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics of lithium effects on glomerular function in bipolar disorder patients under chronic lithium treatment: a pilot study.
    Tsermpini EE; Zhang Y; Niola P; Chillotti C; Ardau R; Bocchetta A; Patrinos GP; Del Zompo M; Severino G; Lee MT; Squassina A
    Neurosci Lett; 2017 Jan; 638():1-4. PubMed ID: 27923663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurons derived from patients with bipolar disorder divide into intrinsically different sub-populations of neurons, predicting the patients' responsiveness to lithium.
    Stern S; Santos R; Marchetto MC; Mendes APD; Rouleau GA; Biesmans S; Wang QW; Yao J; Charnay P; Bang AG; Alda M; Gage FH
    Mol Psychiatry; 2018 Jun; 23(6):1453-1465. PubMed ID: 28242870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of antipsychotic medication and lithium with brain measures in patients with bipolar disorder.
    Abramovic L; Boks MP; Vreeker A; Bouter DC; Kruiper C; Verkooijen S; van Bergen AH; Ophoff RA; Kahn RS; van Haren NE
    Eur Neuropsychopharmacol; 2016 Nov; 26(11):1741-1751. PubMed ID: 27665062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis.
    Hajek T; Kopecek M; Höschl C; Alda M
    J Psychiatry Neurosci; 2012 Sep; 37(5):333-43. PubMed ID: 22498078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential neuroprotective effect of lithium in bipolar patients evaluated by neuropsychological assessment: preliminary results.
    Bersani G; Quartini A; Zullo D; Iannitelli A
    Hum Psychopharmacol; 2016 Jan; 31(1):19-28. PubMed ID: 26563456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment.
    Yucel K; Taylor VH; McKinnon MC; Macdonald K; Alda M; Young LT; MacQueen GM
    Neuropsychopharmacology; 2008 Jan; 33(2):361-7. PubMed ID: 17406649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mini-review: The anti-aging effects of lithium in bipolar disorder.
    Salarda EM; Zhao NO; Lima CNNC; Fries GR
    Neurosci Lett; 2021 Aug; 759():136051. PubMed ID: 34139318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hippocampal subfield volumes in short- and long-term lithium-treated patients with bipolar I disorder.
    Simonetti A; Sani G; Dacquino C; Piras F; De Rossi P; Caltagirone C; Coryell W; Spalletta G
    Bipolar Disord; 2016 Jun; 18(4):352-62. PubMed ID: 27237705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study.
    Lyoo IK; Dager SR; Kim JE; Yoon SJ; Friedman SD; Dunner DL; Renshaw PF
    Neuropsychopharmacology; 2010 Jul; 35(8):1743-50. PubMed ID: 20357761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased mRNA expression of peripheral glial cell markers in bipolar disorder: The effect of long-term lithium treatment.
    Ferensztajn-Rochowiak E; Tarnowski M; Samochowiec J; Michalak M; Ratajczak MZ; Rybakowski JK
    Eur Neuropsychopharmacol; 2016 Sep; 26(9):1516-1521. PubMed ID: 27474686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized controlled trial comparing lithium plus valproic acid versus lithium plus carbamazepine in young patients with type 1 bipolar disorder: the LICAVAL study.
    Missio G; Moreno DH; Demetrio FN; Soeiro-de-Souza MG; Dos Santos Fernandes F; Barros VB; Moreno RA
    Trials; 2019 Oct; 20(1):608. PubMed ID: 31655626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical factors associated with lithium treatment response in bipolar disorder patients from India.
    Kapur V; Nadella RK; Sathur Raghuraman B; Saraf G; Mishra S; Srinivasmurthy N; Jain S; Del Zompo M; Viswanath B
    Asian J Psychiatr; 2019 Jan; 39():165-168. PubMed ID: 29636228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lithium increases cortical and subcortical volumes in subjects with bipolar disorder.
    Jones G; Suchting R; Zanetti MV; Leung E; da Costa SC; Sousa RT; Busatto G; Soares J; Otaduy MC; Gattaz WF; Machado-Vieira R
    Psychiatry Res Neuroimaging; 2022 Aug; 324():111494. PubMed ID: 35640450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations.
    Girardi P; Brugnoli R; Manfredi G; Sani G
    Drugs R D; 2016 Dec; 16(4):293-302. PubMed ID: 27770296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of telomerase reverse transcriptase positively correlates with duration of lithium treatment in bipolar disorder.
    Lundberg M; Biernacka JM; Lavebratt C; Druliner B; Ryu E; Geske J; Colby C; Boardman L; Frye M; Schalling M
    Psychiatry Res; 2020 Apr; 286():112865. PubMed ID: 32114208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Selective Association between Central and Peripheral Lithium Levels in Remitters in Bipolar Depression: A 3T-(7) Li Magnetic Resonance Spectroscopy Study.
    Machado-Vieira R; Otaduy MC; Zanetti MV; De Sousa RT; Dias VV; Leite CC; Forlenza OV; Busatto GF; Soares JC; Gattaz WF
    Acta Psychiatr Scand; 2016 Mar; 133(3):214-20. PubMed ID: 26513535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of genetic and environmental contributions to structural brain changes over time in twins concordant and discordant for bipolar disorder.
    Bootsman F; Brouwer RM; Schnack HG; Kemner SM; Hillegers MHJ; Sarkisyan G; van der Schot AC; Vonk R; Hulshoff Pol HE; Nolen WA; Kahn RS; van Haren NEM
    J Psychiatr Res; 2016 Aug; 79():116-124. PubMed ID: 27218817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lithium: still a cornerstone in the long-term treatment in bipolar disorder?
    Nivoli AM; Murru A; Vieta E
    Neuropsychobiology; 2010; 62(1):27-35. PubMed ID: 20453532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.